Related Experiment Videos

Morphogenesis of amyloid plaques in mice with Creutzfeldt-Jakob disease

Acta Neuropathologica
|January 1, 1985
PubMed

Insights

Researchers found that macrophages produce amyloid fibrils in the brains of mice infected with Creutzfeldt-Jakob disease (CJD). This study sheds light on the cellular mechanisms behind amyloid plaque formation in prion diseases.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Amyloid plaques are a hallmark of neurodegenerative diseases.
  • The cellular origin of amyloid fibrils in prion diseases like Creutzfeldt-Jakob disease (CJD) remains incompletely understood.
  • Previous studies have implicated various cell types in amyloid formation.

Purpose of the Study:

  • To investigate the cellular source of amyloid fibril production in the brains of mice experimentally infected with human CJD.
  • To elucidate the ultrastructural mechanisms by which macrophages interact with and potentially produce amyloid fibrils.

Main Methods:

  • Experimental inoculation of mice with human CJD brain homogenate.
  • Light and ultramicroscopic examination of brain tissue to identify amyloid plaques and associated cells.
  • Detailed ultrastructural analysis of macrophages within amyloid plaque areas.

Main Results:

  • Amyloid plaques were observed in CJD-infected mouse brains, surrounded by macrophages and astrocytes.
  • Ultramicroscopically, amyloid fibrils were found within the cytoplasm of macrophages and in extracellular spaces adjacent to them.
  • Macrophages exhibited active cellular machinery (Golgi apparatus, ER, ribosomes) and contained inoculated material, suggesting a role in amyloid synthesis.
  • Amyloid fibrils were seen projecting from the Golgi apparatus and rough ER of macrophages.

Conclusions:

  • Macrophages are confirmed as the producers of amyloid fibrils in the brains of CJD-infected mice.
  • This study provides ultrastructural evidence for macrophage-mediated amyloidogenesis in prion disease.
  • Understanding this mechanism may offer new therapeutic targets for CJD and related amyloidopathies.

Related Concept Videos